FDA.reportPublic FDA data

DALACIN T

Manufacturer
Pharmacia & Upjohn Company LLC
Effective date
2026-02-10
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 21:59:51

Label at a glance#

ProductDALACIN T
Active ingredientCLINDAMYCIN PHOSPHATE
Label structure1 sections

Label contents#

Full prescribing information#

PRINCIPAL DISPLAY PANEL – Shipping Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

48 (30 GM)
PAA045932

DALACIN T® TOPICAL GEL 1%

STORE AT CONTROLLED ROOM TEMPERATURE BELOW 25°C.
PROTECT FROM FREEZING
FOR EXPORT ONLY.
NOT TO BE SOLD OR OFFERED FOR SALE IN THE USA.

PHARMACIA &
UPJOHN COMPANY
KALAMAZOO,
MICHIGAN 49001,
USA
DIVISION OF
PFIZER INC.
NEW YORK,
NY 10017, USA

Pfizer

EXP: ????????????
LOT: XXXXXXXXXX

PRINCIPAL DISPLAY PANEL – Shipping Label
PRINCIPAL DISPLAY PANEL – Shipping Label

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLINDAMYCIN Pharmacologic Class Indexing3Indexing - Pharmacologic Class20210811

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 128(17)000000(10)XXXXXXXXXXcleocin-01.jpg
Data codeCode 128(30)00cleocin-01.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
1426d8f8-b7d5-4053-8554-613df00c0d86Product name220250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d8f81258-db12-0761-46cc-8ff6e62e9302Product name420240422
b7b2fa42-1c77-d724-81f0-87da60a77e79Product name320240320
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0Product name320230425
e3af9708-3004-7392-4046-5311eaa8bab5Product name320221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3Product name920220928
b72227d6-0388-43bd-995b-b762d2754cd5Product name120220706
a92d22e0-3af4-f301-bc88-27ff030b0070Product name220220316
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
5ce6ce33-4f2b-3ce0-757d-e520013280cfProduct name520180719
b92a26f1-6926-4817-be73-e26ab4c2146fProduct name120170602
028d6c95-5012-6976-2075-dee0ae6fefe2Product name120140508
468b2c08-8adb-8d0f-8257-c6515a061424Product name120140508
8959fb29-d86f-c521-666a-b4cb22233594Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0009-1208-01DALACIN T30 g in 1 TUBEGEL301
0009-1208-02DALACIN T1 in 1 CARTONGEL11
0009-1208-48DALACIN T48 in 1 CASEGEL481

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0009-12080009-1208-01, 0009-1208-02, 0009-1208-48

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
NameUNIIKind
CLINDAMYCIN PHOSPHATEEH6D7113I8ACTIM
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)HHT01ZNK31IACT
ALLANTOIN344S277G0ZIACT
METHYLPARABENA2I8C7HI9TIACT
POLYETHYLENE GLYCOL 400B697894SGQIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
SODIUM HYDROXIDE55X04QC32IIACT
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a7d54ae5-6830-4e11-b655-345569fb5aeda7d54ae5-6830-4e11-b655-345569fb5aed2026-02-10Exact identifier
spl id: a7d54ae5-6830-4e11-b655-345569fb5aed
spl set id: a7d54ae5-6830-4e11-b655-345569fb5aed

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.